Confirms Single Phase 3 Immuno-Bridging Trial Sufficient to Evaluate Efficacy and to Support a Marketing Authorization ...

On April 22, 2024, the Office of Management and Budget (OMB) released significant revisions to Title 2 of the Code of Federal ...